Edition:
United States

Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

603.60INR
8 Dec 2017
Change (% chg)

Rs11.10 (+1.87%)
Prev Close
Rs592.50
Open
Rs599.50
Day's High
Rs608.00
Day's Low
Rs592.50
Volume
50,491
Avg. Vol
117,424
52-wk High
Rs663.00
52-wk Low
Rs479.00

Latest Key Developments (Source: Significant Developments)

Cipla Launches Q-Tib Globally
Thursday, 30 Nov 2017 02:29am EST 

Nov 30 (Reuters) - Cipla Ltd ::SAYS CIPLA LAUNCHES Q-TIB GLOBALLY.SAYS GOT APPROVAL FOR PRODUCT Q-TIB FROM WORLD HEALTH ORGANISATION.Q-TIB WILL HELP PREVENT TUBERCULOSIS INFECTION IN PEOPLE LIVING WITH HIV.  Full Article

Cipla gets final approval for generic Dacogen​
Sunday, 19 Nov 2017 10:22pm EST 

Nov 20 (Reuters) - Cipla Ltd :Says ‍Cipla receives final approval for generic Dacogen​.Drug indicated for treatment of patients with myelodysplastic syndromes.Product is available for shipping immediately.  Full Article

Cipla gets final approval for generic Pulmicort Respules
Thursday, 16 Nov 2017 10:25pm EST 

Nov 17 (Reuters) - Cipla Ltd ::Cipla receives final approval for generic Pulmicort Respules.Drug indicated for maintenance treatment of asthma, as prophylactic therapy in children 12 months to 8 years of age.Product available for shipping immediately.  Full Article

India's Cipla Sept qtr consol profit up about 19 pct
Tuesday, 7 Nov 2017 03:26am EST 

Nov 7 (Reuters) - Cipla Ltd :Sept quarter consol net profit 4.23 billion rupees versus profit of 3.54 billion rupees last year.Consensus forecast for sept quarter consol net profit was 4.20 billion rupees.Sept quarter consol net sales 39.88 billion rupees versus 36.72 billion rupees last year.  Full Article

Cipla says US unit gets USFDA final approval for generic Renvela tablets‍​
Friday, 27 Oct 2017 01:23am EDT 

Oct 27 (Reuters) - Cipla Ltd :Says us subsidiary receives final approval for generic Renvela tablets‍​.  Full Article

Cipla's U.S. unit gets final FDA nod for generic Renvela tablets
Thursday, 26 Oct 2017 11:26pm EDT 

Oct 27 (Reuters) - Cipla Ltd ::Says co's U.S. unit gets final FDA nod for generic Renvela tablets ‍​.  Full Article

Cipla says co on target to ramp-up launch trajectory in U.S.‍​
Friday, 11 Aug 2017 04:19am EDT 

Aug 11 (Reuters) - Cipla Ltd :Says "we are on target to ramp-up our launch trajectory in the U.S.”‍​.  Full Article

India's Cipla June-qtr consol profit up about 21 pct
Friday, 11 Aug 2017 04:09am EDT 

Aug 11 (Reuters) - Cipla Ltd :June quarter consol net profit 4.09 billion rupees versus 3.39 billion rupees last year.Consensus forecast for june quarter consol net profit was 3 billion rupees.June quarter consol net sales 34.32 billion rupees versus 35.56 billion rupees last year.  Full Article

India's Cipla launches rectal artesunate suppositories for severe malaria in young children
Tuesday, 25 Jul 2017 06:04am EDT 

July 25 (Reuters) - Cipla Ltd :Launches quality-assured rectal artesunate suppositories for severe malaria in young children.Says co's RAS product will now soon be available in four sub-Saharan countries.  Full Article

Perrigo announces settlement of generic version of dymista nasal spray patent litigation
Monday, 17 Jul 2017 09:06am EDT 

July 17 (Reuters) - Perrigo Company Plc ::Perrigo announces settlement of generic version of dymista nasal spray patent litigation.Perrigo Company Plc - ‍settled hatch-waxman litigation relating to dymista nasal spray brought by MEDA Pharmaceuticals Inc and Cipla Ltd​.  Full Article

BRIEF-Cipla Launches Q-Tib Globally

* SAYS GOT APPROVAL FOR PRODUCT Q-TIB FROM WORLD HEALTH ORGANISATION